IP Library › Granted Patent US 10,465,197
Granted Patent B2
US 10,465,197 · App. 14/952,535 · Granted Nov 5, 2019

Inducible expression system

Inventors: Sean McClain (Portland, OR); Mark Valasek (San Diego, CA)
Assignee: AbiSci, LLC
C12N15/70C07K16/241C07K16/2803C12P21/02C07K2317/14C07K2317/20C07K2317/21C07K2317/24C07K2317/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,465,197
App. No.
14/952,535
Granted
Nov 5, 2019
Kind
B2
Abstract

The present invention is an inducible coexpression system, capable of controlled induction of expression of each gene product.

Claims (27)

1. A composition comprising a host cell and at least one inducer;

wherein the host cell comprises at least one extrachromosomal expression construct comprising at least one first Escherichia coli sugar-inducible promoter and at least one polynucleotide sequence encoding a polypeptide, wherein at least one said polynucleotide sequence is to be transcribed from said first inducible promoter, wherein the polypeptide lacks a signal peptide; and

wherein the host cell comprises at least one extrachromosomal expression construct comprising at least one second inducible promoter, selected from the group consisting of an Escherichia coli sugar-inducible promoter and a propionate-inducible promoter, that is inducible by at least one inducer that is different than that of said first inducible promoter; and

wherein none of said inducible promoters is a lactose-inducible promoter; and

wherein the host cell has an altered gene function of at least one gene that affects the reduction/oxidation environment of the host cell cytoplasm; and

wherein the host cell has a reduced level of gene function of at least one gene encoding a protein that metabolizes an inducer of at least one said inducible promoter; and

wherein each inducer is selected from the group consisting of a sugar and propionate.

2. The composition of claim 1 wherein at least one inducible promoter is selected from the group consisting of an L-arabinose-inducible promoter, a propionate-inducible promoter, a rhamnose-inducible promoter, and a xylose-inducible promoter.

3. The composition of claim 2 wherein at least one inducible promoter is an L-arabinose-inducible promoter.

4. The composition of claim 2 wherein at least one inducible promoter is selected from the group consisting of: the araBAD promoter, the prpBCDE promoter, the rhaSR promoter, and the xlyA promoter.

5. The composition of claim 1 wherein the polypeptide lacking a signal peptide comprises a polypeptide sequence selected from the group consisting of: (a) a polypeptide chain of mature insulin; (b) a botulinum neurotoxin heavy chain; (c) a botulinum neurotoxin light chain; (d) a chaperone; (e) an immunoglobulin heavy chain; (f) an immunoglobulin light chain; (g) a manganese peroxidase; (h) an arabinose-utilization enzyme; (i) a xylose-utilization enzyme; (j) a lignin-degrading peroxidase; and (k) a fragment of any of (e)-(g).

6. The composition of claim 1 wherein the at least one gene that affects the reduction/oxidation environment of the host cell cytoplasm is selected from the group consisting of gor, gshA, gshB, and trxB.

7. The composition of claim 1 wherein at least one gene encoding a protein that metabolizes an inducer of at least one said inducible promoter is selected from the group consisting of araA, araB, araD, prpB, prpD, rhaA, rhaB, rhaD, xylA, and xylB.

8. The composition of claim 1 wherein at least one inducer is L-arabinose.

9. The composition of claim 8 wherein at least one inducer is L-arabinose added to the composition per host cell density (OD 600 ) of 0.5 at a concentration of less than 0.01%.

10. The composition of claim 9 wherein at least one inducer is L-arabinose added to the composition per host cell density (OD 600 ) of 0.5 at a concentration of 0.002%.

11. The composition of claim 1 wherein the host cell comprises at least one expression construct encoding at least one disulfide bond isomerase protein.

12. The composition of claim 1 wherein the host cell comprises at least one polynucleotide encoding a form of DsbC lacking a signal peptide.

13. The composition of claim 1 wherein the host cell comprises at least one polynucleotide encoding Erv1p.

14. The composition of claim 1 wherein the host cell has an alteration of gene function of at least one gene encoding a transporter protein for an inducer of at least one said inducible promoter.

15. The composition of claim 14 wherein at least one gene encoding a transporter protein is selected from the group consisting of araE, araF, araG, araH, rhaT, xylF, xylG, and xylH.

16. The composition of claim 1 wherein the host cell is a prokaryotic cell.

17. The composition of claim 16 wherein the host cell is E. coli.

18. The composition of claim 1 wherein at least one inducer is selected from the group consisting of L-arabinose, L-rhamnose, D-xylose, and propionate.

19. The composition of claim 18 wherein at least one inducer is present in the composition at a concentration per host cell density (OD 600 ) of 0.5, and is selected from the group consisting of: L-arabinose at a concentration of less than 0.1%; L-rhamnose at a concentration between 5% and 0.002%; D-xylose at a concentration between 5% and 0.002%; and propionate at a concentration between 1 M and 1 mM.

20. The composition of claim 19 wherein at least one inducer is L-arabinose present in the composition per host cell density (OD 600 ) of 0.5 at a concentration of less than 0.05%.

21. The composition of claim 1 wherein said expression construct comprising at least one first inducible promoter, and said expression construct comprising at least one second inducible promoter, are maintained on the same extrachromosomal polynucleotide.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 055921 FRAME: 0049. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded Jan 4, 2023
From: MCCLAIN, SEAN; VALASEK, MARK
To: ABSCI, LLC
Reel/Frame 062291/0288 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2022
From: ABSCI, LLC
To: ABSCI CORPORATION
Reel/Frame 061336/0116 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2021
From: MCCLAIN, SEAN; VALASEK, MARK
To: ABSCI LLC
Reel/Frame 055921/0049 →
Continuity (4)
Continuation 14419653
Provisional Application 61747246 · Dec 29, 2012
Provisional Application 61679751 · Aug 5, 2012
Related Publication 20160152701A1 · Jun 2, 2016
Cited By (4)
US 12,351,850 US 12,409,211 US 12,410,393 US 12,673,983